PTEN and neoplasm: The laboratory sent the tumor specimen, and the patient supplied a normal-matched sample (saliva) that confirmed the pathogenic PTEN G132D missense mutation as a germline variant via NGS (Tempus/GeneDX, xT Solid Tumor + Normal Match 648 gene panel & xG+ 77 gene panel for confirmation).